Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LTR Pharma Limited ( (AU:LTP) ) has shared an announcement.
LTR Pharma Limited has acquired a 33% equity stake in LevOmega Pty Ltd, a company co-founded with Levur Pty Ltd and Green Blue Health Pty Ltd, focusing on the development of nature-identical, pharmaceutical-grade omega-3 oil. This strategic investment positions LTR Pharma to capitalize on the growing demand for sustainable omega-3 solutions, addressing global supply constraints and aligning with its strategy of innovation in large healthcare markets.
More about LTR Pharma Limited
LTR Pharma Limited operates in the pharmaceutical industry, focusing on the development of first-in-class therapies for large markets with unmet needs. The company is known for its intranasal pharmaceutical programs and has products like SPONTAN® and ROXUS® for erectile dysfunction and OROFLOW® for oesophageal motility disorders.
Average Trading Volume: 859,406
Technical Sentiment Signal: Strong Buy
Learn more about LTP stock on TipRanks’ Stock Analysis page.